Zobrazeno 1 - 10
of 14
pro vyhledávání: '"B R Varun"'
Publikováno v:
Indian Journal of Dental Research, Vol 33, Iss 3, Pp 282-286 (2022)
Background: Galectin 3 (Gal-3) has diverse functions critical in cancer biology including cell proliferation, apoptosis, evasion of immune responses and angiogenesis. The expression of Gal-3 is heterogeneous in normal and neoplastic tissues. In oral
Externí odkaz:
https://doaj.org/article/0db3192513374eccae5110b67225192f
Autor:
P., Jayanthi1, B. R., Varun2, T., Nripan1 nripan.t@gmail.com, N. S., Sreena3, Joseph, Anna P.2
Publikováno v:
Journal of Cancer Research & Therapeutics. 2023 Supplement, Vol. 19, pS994-S997. 4p.
Publikováno v:
Journal of Advances in Medicine and Medical Research. :74-82
Epithelial Mesenchymal Transition (EMT) is a crucial process in embryogenesis, however it also plays an important role in pathologies including inflammation, wound healing and cancer. EMT is a determining step in cancer metastasis as tumour cells uti
Publikováno v:
Oral & Maxillofacial Pathology Journal; Jul-Dec2023, Vol. 14 Issue 2, p190-193, 4p
Publikováno v:
Indian Journal of Dental Research; Jul-Sep2022, Vol. 33 Issue 3, p282-286, 5p
Publikováno v:
Journal of Oral and Maxillofacial Pathology : JOMFP
Background: Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that acts as a binding site for toxic chemicals, particularly the dioxin group of chemicals. Elevated levels of AHR have been observed in various human cancers, in
Publikováno v:
Oral surgery, oral medicine, oral pathology and oral radiology. 131(2)
The objective of this study was to evaluate aquaporin-3 (AQP3) expression in patient samples of oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC), thereby assessing the potential of AQP3 as a molecular marker for tumor progressi
Publikováno v:
Journal of Oral and Maxillofacial Pathology : JOMFP
Cancer stem cells (CSCs) are distinct subpopulations of tumor cells that possess the ability for perpetual self-renewal and proliferation. They produce downstream progenitor cells and cancer cells that drive tumor growth. Studies of many cancer types
Autor:
M. S., Lekshmy, Sivakumar, T. T., Joseph, Anna P., B. R., Varun, Mony, Vinod, A., Reshmi, Sudhakar, Sunjith
Publikováno v:
Oral & Maxillofacial Pathology Journal; Jan-Jun2020, Vol. 11 Issue 1, p16-19, 4p
Publikováno v:
Journal of Oral and Maxillofacial Pathology : JOMFP
Background: Bisphosphonate therapy is widely used for the treatment of bone metastasis in breast cancer patients. Aim: The aim of this study is to estimate the overall prevalence of bisphosphonate induced osteonecrosis of jaw (BONJ) in breast cancer